Expert Pitch
American University

World AIDS Day During COVID-19: AU Experts Offer Insights

23-Nov-2020 4:25 PM EST, by American University

World AIDS Day During COVID-19: AU Experts Offer Insights

What: How have lessons from the HIV/AIDS pandemic inform our response to COVID-19? What has been the impact of COVID-19 on people living with HIV/AIDS and HIV research? AU experts are available to share their insights into these and many other questions.  

When: November 23, 2020 - ongoing

How: Facetime, Skype, phone or Zoom

Background: AU experts who are available for interviews include:

Prof. Kim Blankenship is a sociologist in AU’s College of Arts and Sciences and Co-Director of the Developmental Core of the District of Columbia Center for AIDS Research, or DC CFAR. She is also Director of AU’s Center on Health, Risk and Society. Blankenship can discuss inequities with regard to HIV risk and treatment-related outcomes; how policies and practices related to policing, incarceration, and housing instability relate to HIV; and the lessons from HIV in approaches to fighting COVID-19 such as disease risk, inequities in vulnerability to the virus, trust in the medical system/medical science, and the social nature of disease.

Rachel Sullivan Robinson is an associate professor in the School of International Service at American University. Her research focuses on sex-related health interventions in sub-Saharan Africa, including family planning, HIV/AIDS, and sexuality education. Robinson can comment on the intersections of COVID-19 and HIV, particularly how HIV interventions have, and have not, prepared countries for addressing COVID-19.   

Nina Yamanis is an associate professor in the School of International Service. Her research focuses on health disparities and community-based interventions to improve health among vulnerable groups, and the role of social networks in HIV transmission. In 2017 she was awarded a grant from the Robert Wood Johnson Foundation to examine resilience and health in immigrant communities in Washington, D.C. and Prince George’s County, Maryland. Prof. Yamanis is available to comment on issues related to U.S. Latinx immigrants, including the undocumented, and access to health care, and HIV, and how to reach under-served and vulnerable populations with public health interventions. 

 

About American University

In its 127-year history, American University has established a reputation for producing change makers focused on the challenges of a changing world. AU has garnered recognition for global education, public service, experiential learning and politically active and diverse students, as well as academic and research expertise in a wide range of areas including the arts, sciences, humanities, business and communication, political science and policy, governance, law and diplomacy.

 




Filters close

Showing results

110 of 4573
Released: 15-Jan-2021 5:40 PM EST
Research Links Social Isolation to COVID-19 Protocol Resistance
Humboldt State University

As health officials continue to implore the public to wear masks and practice social distancing, recent research by Humboldt State University Psychology Professor Amber Gaffney provides key insights into connections between social isolation, conspiratorial thinking, and resistance to COVID-19 protocols.

Newswise: Rapid blood test identifies COVID-19 patients at high risk of severe disease
Released: 15-Jan-2021 5:35 PM EST
Rapid blood test identifies COVID-19 patients at high risk of severe disease
Washington University in St. Louis

Scientists at Washington University School of Medicine in St. Louis have shown that a relatively simple and rapid blood test can predict which patients with COVID-19 are at highest risk of severe complications or death. The blood test measures levels of mitochondrial DNA, which normally resides inside the energy factories of cells. Mitochondrial DNA spilling out of cells and into the bloodstream is a sign that a particular type of violent cell death is taking place in the body.

Released: 15-Jan-2021 2:55 PM EST
COVID-19 deaths really are different. But best practices for ICU care should still apply, studies suggest.
Michigan Medicine - University of Michigan

COVID-19 deaths are indeed different from other lung failure deaths, according to two recent studies, with 56% of COVID-19 patients dying primarily from the lung damage caused by the virus, compared with 22% of those whose lungs fail due to other causes. But, the researchers conclude, the kind of care needed to help sustain people through the worst cases of all forms of lung failure is highly similar, and just needs to be fine-tuned.

Released: 15-Jan-2021 2:50 PM EST
45% of adults over 65 lack online medical accounts that could help them sign up for COVID-19 vaccinations
Michigan Medicine - University of Michigan

As the vaccination of older adults against COVID-19 begins across the country, new poll data suggests that many of them don’t yet have access to the “patient portal” online systems that could make it much easier for them to schedule a vaccination appointment. In all, 45% of adults aged 65 to 80 had not set up an account with their health provider’s portal system.

Released: 15-Jan-2021 1:30 PM EST
New England Journal of Medicine publishes COVID-19 treatment trial results
University of Texas at San Antonio

A clinical trial involving COVID-19 patients hospitalized at UT Health San Antonio and University Health, among roughly 100 sites globally, found that a combination of the drugs baricitinib and remdesivir reduced time to recovery, according to results published Dec. 11 in the New England Journal of Medicine.

Released: 15-Jan-2021 12:40 PM EST
DNA test can quickly identify pneumonia in patients with severe COVID-19, aiding faster treatment
University of Cambridge

Researchers have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation than non-COVID-19 patients.

Released: 15-Jan-2021 12:30 PM EST
Fight CRC To Present Research Findings on The Impact of COVID-19 on the Colorectal Cancer Community at 2021 GI ASCO
Fight Colorectal Cancer

Fight Colorectal Cancer presents abstract at Gastrointestinal Cancer Symposium highlighting the need to address the barriers and opportunities for care within the colorectal cancer community during the COVID-19 pandemic

Released: 15-Jan-2021 12:25 PM EST
Technion to Award Honorary Doctorate to Pfizer CEO Dr. Albert Bourla
American Technion Society

Israel's Technion will award an honorary doctorate to Pfizer CEO and Chairman Dr. Albert Bourla, for leading the development of the novel vaccine against SARS-CoV-2, the virus that causes COVID-19. The honorary doctorate will be conferred at the Technion Board of Governors meeting in November 2021.

Released: 15-Jan-2021 11:30 AM EST
UW researchers develop tool to equitably distribute limited vaccines
University of Wisconsin-Madison

Researchers at the University of Wisconsin School of Medicine and Public Health and UW Health have developed a tool that incorporates a person’s age and socioeconomic status to prioritize vaccine distribution among people who otherwise share similar risks due to their jobs.


Showing results

110 of 4573

close
1.14075